TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Dr. Hoenle AG ( (DE:HNL) ) is now available.
Dr. Hönle AG has announced a reduction in voting rights held by Gerlin Participaties Coöperatief U.A., from 4.49% to 2.98% as of December 19, 2024. This change is significant as it indicates a decrease in the shareholder’s influence, potentially impacting decision-making and company control dynamics.
More about Dr. Hoenle AG
Dr. Hönle AG is based in Gilching, Germany, and operates within the technology sector. The company is listed on the regulated market in Frankfurt and the free market in other German cities. It is known for its technological products and services, although specific offerings are not detailed in the release.
Average Trading Volume: 2,260
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €45.46M
For a thorough assessment of HNL stock, go to TipRanks’ Stock Analysis page.

